Document is current
Any future updates will be listed below
-
Authors
Tanabe, Yuko
Shiraishi, Seiji
Hashimoto, Kenji
Ikeda, Kazutaka
Nishizawa, Daisuke
Hasegawa, Junko
Shimomura, Akihiko
Ozaki, Yukinori
Tamura, Nobuko
Yunokawa, Mayu
Yonemori, Kan
Takano, Toshimi
Kawabata, Hidetaka
Tamura, Kenji
Fujiwara, Yasuhiro
Shimizu, Chikako
-
Funding
Funding for this research was provided by:
Scientific Research Grant from the Ministry of Health, Labor, and Welfare (H21- 021)
National Cancer Center Research and Development Fund (23-A-30, 26-A-20)
Okinaka Memorial Institute for Medical Disease (No. 2018-23)
- License Information
-
More Information
Article History
Received: 27 November 2019
Accepted: 6 April 2020
First Online: 16 April 2020
Ethics approval and consent to participate
: All patients provided written informed consent for adjuvant treatment and DNA collection for genetic analysis. The study was conducted in accordance with the Declaration of Helsinki and was approved by the institutional review board of National Cancer Center Hospital and Toranomon Hospital. (protocol number: 2013–199).
: Not applicable.
: The authors have no competing interests to declare.
